0001209191-15-058922.txt : 20150702
0001209191-15-058922.hdr.sgml : 20150702
20150702164231
ACCESSION NUMBER: 0001209191-15-058922
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150701
FILED AS OF DATE: 20150702
DATE AS OF CHANGE: 20150702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIMERIX INC
CENTRAL INDEX KEY: 0001117480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330903395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 340
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919.806.1074
MAIL ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 340
CITY: DURHAM
STATE: NC
ZIP: 27713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DEMSKI MARTHA J
CENTRAL INDEX KEY: 0001198230
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35867
FILM NUMBER: 15970366
MAIL ADDRESS:
STREET 1: 9373 TOWNE CENTRE DRIVE SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121-3088
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-07-01
0
0001117480
CHIMERIX INC
CMRX
0001198230
DEMSKI MARTHA J
C/O CHIMERIX, INC.
2505 MERIDIAN PARKWAY, SUITE 340
DURHAM
NC
27713
1
0
0
0
Common Stock
2015-07-01
4
M
0
2000
1.53
A
2000
D
Common Stock
2015-07-01
4
S
0
1300
45.70
D
700
D
Common Stock
2015-07-01
4
S
0
700
46.63
D
0
D
Common Stock
14788
I
By the Martha J. Demski Trust u/a 10/01/94
Stock Option (Right to Buy)
1.53
2015-07-01
4
M
0
2000
0.00
D
2018-06-25
Common Stock
2000
7126
D
The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on September 15, 2014.
The range of sale prices received is $45.24 to $46.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares sold at each separate price.
The range of sale prices received is $46.32 to $46.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares sold at each separate price.
Immediately exercisable.
/s/ Michael Alrutz, Attorney-In-Fact
2015-07-02